Follow The Filings

ORKA Oruka Therapeutics

Oruka Therapeutics earnings company data as of 4:47 AM ET 10/22

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by ORKA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ORKA insider trades
  • None no insider bought on the open market
  • $300M sold by 1 insider outside a trading plan
  • $36.6M sold by 6 insiders under 10b5-1 plans
  1. Paul T Quinlan General Counsel
    Planned sale
    $707K 9,000 shares at $78.53 23% of stake
    Traded Oct 20 Filed Oct 20
    ↗
  2. Joana Goncalves Chief Medical Officer
    Planned sale
    $524K 7,000 shares at $74.81 18% of stake
    Traded Oct 15 Filed Oct 15
    ↗
  3. Arjun Agarwal Senior Vice President, Finance
    Planned sale
    $806K 9,999 shares at $80.60 41% of stake
    Traded Oct 12 Filed Oct 13
    ↗
  4. Lawrence Otto Klein CEO
    Planned sale
    $2.1M 25,000 shares at $83.62 2.6% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  5. Arjun Agarwal Senior Vice President, Finance
    Planned sale
    $51K 533 shares at $95.75 3.6% of stake
    Traded Sep 21 Filed Sep 21
    ↗
  6. Paul T Quinlan General Counsel
    Planned sale
    $936K 10,000 shares at $93.64 25% of stake
    Traded Sep 21 Filed Sep 21
    ↗
  7. Joana Goncalves Chief Medical Officer
    Planned sale
    $644K 7,000 shares at $91.93 18% of stake
    Traded Sep 15 Filed Sep 15
    ↗
  8. Arjun Agarwal Senior Vice President, Finance
    Planned sale
    $872K 9,459 shares at $92.23 38% of stake
    Traded Sep 11 Filed Sep 15
    ↗
  9. Laura Lee Sandler COO
    Planned sale
    $459K 5,000 shares at $91.82 2.1% of stake
    Traded Sep 1 Filed Sep 1
    ↗
  10. Lawrence Otto Klein CEO
    Planned sale
    $6.9M 75,000 shares at $91.83 7.5% of stake
    Traded Sep 1 Filed Sep 1
    ↗
  11. Joana Goncalves Chief Medical Officer
    Planned sale
    $783K 7,000 shares at $111.84 18% of stake
    Traded Aug 17 Filed Aug 17
    ↗
  12. Paul T Quinlan General Counsel
    Planned sale
    $5.6M 52,000 shares at $108.49 63% of stake
    Traded Aug 14 Filed Aug 14
    ↗
  13. Arjun Agarwal Senior Vice President, Finance
    Planned sale
    $1.1M 10,000 shares at $106.66 40% of stake
    Traded Aug 13 Filed Aug 14
    ↗
  14. Joana Goncalves Chief Medical Officer
    Planned sale
    $604K 7,000 shares at $86.28 18% of stake
    Traded Jul 15 Filed Jul 15
    ↗
  15. Arjun Agarwal Senior Vice President, Finance
    Planned sale
    $846K 9,999 shares at $84.63 40% of stake
    Traded Jul 13 Filed Jul 13
    ↗

Also filed in the last 12 months, not counted as buying or selling: 48 option exercises, 15 sales to cover taxes, 6 stock grants, 1 conversion, and 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
424B5 PROSPECTUS Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 5.07 Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.